Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-012648
Filing Date
2013-03-04
Accepted
2013-03-04 16:17:53
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v334209_10k.htm 10-K 1039209
2 EXHIBIT 23.1 v334209_ex23-1.htm EX-23.1 2402
3 EXHIBIT 31.1 v334209_ex31-1.htm EX-31.1 10682
4 EXHIBIT 31.2 v334209_ex31-2.htm EX-31.2 10452
5 EXHIBIT 32 v334209_ex32.htm EX-32 5529
12 GRAPHIC tpg8.jpg GRAPHIC 53388
  Complete submission text file 0001144204-13-012648.txt   6092816

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acur-20121231.xml EX-101.INS 806453
7 XBRL TAXONOMY EXTENSION SCHEMA acur-20121231.xsd EX-101.SCH 53742
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20121231_cal.xml EX-101.CAL 32114
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20121231_def.xml EX-101.DEF 271401
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20121231_lab.xml EX-101.LAB 469551
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20121231_pre.xml EX-101.PRE 326619
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 13661856
SIC: 2834 Pharmaceutical Preparations